Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael H Pillinger

Showing results (21-30 of 148) with videos related to

Pageof 15
Sort By:
Drugs of Today (Barcelona, Spain : 1998)|June 6, 2009
Febuxostat: a new agent for lowering serum urateRobert T Keenan, Michael H Pillinger
Bulletin of the NYU Hospital for Joint Diseases|October 22, 2008
Update on the management of hyperuricemia and goutMichael H Pillinger, Robert T Keenan
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|February 26, 2009
The anti-inflammatory effects of prostaglandinsJose U Scher, Michael H Pillinger
The American Journal of Medicine|March 21, 2013
Saturnine gout, redux: a reviewSam R Dalvi, Michael H Pillinger
Bulletin of the NYU Hospital for Joint Diseases|November 1, 2011
The year in gout - 2010-2011Daria B Crittenden, Michael H Pillinger
Bulletin of the Hospital for Joint Disease (2013)|October 25, 2013
The year in gout: 2012-2013 - a walk through the 2012 ACR Gout Treatment GuidelinesDaria B Crittenden, Michael H Pillinger
ACR Open Rheumatology|November 29, 2019
Febuxostat and the Black Box BluesAryeh M Abeles, Michael H Pillinger
Annual Review of Medicine|January 19, 2013
New therapies for goutDaria B Crittenden, Michael H Pillinger
Bulletin of the Hospital for Joint Disease (2013)|May 26, 2018
Autoimmune Tracheal Cartilage Inflammation Responsive to Anti-TNF-α TherapyAllison Guttmann, Michael H Pillinger, Svetlana Krasnokutsky
Current Rheumatology Reports|October 23, 2015
Gout in the Spine: Imaging, Diagnosis, and OutcomesMichael Toprover, Svetlana Krasnokutsky, Michael H Pillinger
Pageof 15

Showing results (21-30 of 148) with videos related to

Sort By:
Pageof 15
Drugs of Today (Barcelona, Spain : 1998)|June 6, 2009
Febuxostat: a new agent for lowering serum urateRobert T Keenan, Michael H Pillinger
Bulletin of the NYU Hospital for Joint Diseases|October 22, 2008
Update on the management of hyperuricemia and goutMichael H Pillinger, Robert T Keenan
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|February 26, 2009
The anti-inflammatory effects of prostaglandinsJose U Scher, Michael H Pillinger
The American Journal of Medicine|March 21, 2013
Saturnine gout, redux: a reviewSam R Dalvi, Michael H Pillinger
Bulletin of the NYU Hospital for Joint Diseases|November 1, 2011
The year in gout - 2010-2011Daria B Crittenden, Michael H Pillinger
Bulletin of the Hospital for Joint Disease (2013)|October 25, 2013
The year in gout: 2012-2013 - a walk through the 2012 ACR Gout Treatment GuidelinesDaria B Crittenden, Michael H Pillinger
ACR Open Rheumatology|November 29, 2019
Febuxostat and the Black Box BluesAryeh M Abeles, Michael H Pillinger
Annual Review of Medicine|January 19, 2013
New therapies for goutDaria B Crittenden, Michael H Pillinger
Bulletin of the Hospital for Joint Disease (2013)|May 26, 2018
Autoimmune Tracheal Cartilage Inflammation Responsive to Anti-TNF-α TherapyAllison Guttmann, Michael H Pillinger, Svetlana Krasnokutsky
Current Rheumatology Reports|October 23, 2015
Gout in the Spine: Imaging, Diagnosis, and OutcomesMichael Toprover, Svetlana Krasnokutsky, Michael H Pillinger
Pageof 15